4.5 Article

TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces

Journal

VACCINE
Volume 25, Issue 29, Pages 5348-5358

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2007.05.029

Keywords

dendritic cells; mucosa; adjuvant

Funding

  1. NICHD NIH HHS [HD17557, R01 HD017557] Funding Source: Medline
  2. NIDDK NIH HHS [DK34854] Funding Source: Medline

Ask authors/readers for more resources

Proteosome-based vaccines have TLR2-based adjuvant activity and show promise for mucosal immunization. We examined the effects of proteosomes on mucosal uptake in Peyer's patches in vivo. Proteosomes accelerated transepithelial transport of microparticles by M cells and induced migration of dendritic cells (DCs) into the follicle-associated epithelium (FAE); both effects were dependent on TLR2. Proteosomes induced the release of the DC-attracting chemokine MIP3 alpha from Caco-2 epithelial cells in vitro. In HEK cells, proteosome-mediated MIP3 alpha release was dependent on TLR2 expression and matrix metalloproteinase activation. Thus, TLR2 activation by proteosomes may promote mucosal uptake of particulate vaccines, and this may contribute to their adjuvanticity. (c) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available